Published in

Advances in Healthcare Information Systems and Administration, p. 32-57, 2023

DOI: 10.4018/978-1-6684-8337-4.ch003

Links

Tools

Export citation

Search in Google Scholar

Artificial Intelligence and Its Integration with Regenerative Medicine Approach

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Artificial intelligence (AI) and regenerative medicine are becoming inextricably linked. As a result, the long-term outlook for the advancement of AI, regenerative medicine, and stem cells in the healthcare industry is incredibly bright. AI is being used in healthcare to discover new drugs and to provide personalized medicine based on big data. It can improve medical diagnosis and treatment plans. Regenerative medicine has the potential to repair damaged tissues and organs through stem cell-based regenerative medicine. Stem cell research is also undergoing significant development as a major component of the approach to regenerative medicine. In the future, it is expected that it will contribute to more personalized and more effective treatments. Integrating AI can help model and simulate cellular behavior, analyze, and process images for cell tracking and tissue engineering, and analyze large amounts of genomic and proteomic data. Together, these fields have the potential to transform healthcare and improve patient outcomes.